Peripheral Interventions Market Size By Product (Catheters, Sheath, Stents {Bare-metal Stents, Drug-eluting Stents}, Guide Wires, Atherectomy Devices, Embolic Devices, Thrombectomy Devices, IVC Filters), By Application (Peripheral Artery Disease, Venous Thromboembolism), By End-use (Hospitals, Catheterization Laboratories, Ambulatory Surgical Centres), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 – 2028

Industry trends

Peripheral Interventions Market size was valued at USD 7.9 billion in 2021 and is expected to witness over 8.5% CAGR between 2022 and 2028. Expanding prevalence of cardiovascular disorders (CVD) will be a major factor creating high demand for peripheral interventions. Hypertension, diabetes mellitus, excess weight, smoking and increasing consumption of carbohydrate-rich food are the primary factors of development of some form of CVD.
 

To get more details on this report: Request Free Sample PDF
 

Rising number of catheterization laboratories coupled with increasing number of healthcare professionals in emerging markets will impel the industry growth. Growing adoption of treatment for CVD in catheterization laboratories (cath labs) is growing robustly, especially in developing countries. Also, emergence of hybrid catheterization labs that are utilized for not only cardiac peripheral interventions, but also vascular, neurological, electrophysiology and other procedures has increased during the past years.
 

The number of cath labs in India has increased by more than two-fold, with a significant increase in the number of peripheral interventions procedures. Also, rise in the number of angioplasties, due to increase in CVDs augmented healthcare spending throughout the globe. Rise in the number of peripheral interventions professionals and catheterization laboratories are anticipated to drive the industry expansion.
 

The COVID-19 pandemic has disrupted the medical services like peripheral intervention practises, as screening programmes and services have been reduced or suspended in several countries. Reduction in the number of patients presenting to the emergency department (ED) with peripheral artery disease is predicted to have a negative impact on peripheral interventional procedures and device acceptance.
 

Furthermore, guidewires, catheters and stents are essential medical devices, used in critical life-saving procedures. Thus, was estimated that the COVID-19 crisis did not directly impact the manufacturing of such peripheral interventions’ devices market. However, logistical interruptions disrupted the supply of guidewires, stents and catheters and cause temporary shortages. This had potentially increased the price of guidewires.
 

Rising expenditure in research and development will stimulate the peripheral interventions market growth

The government and major companies have significantly increased R&D expenditure due to the high pervasiveness of cardiovascular disease. Governmental support for the launch of novel devices is projected to contribute to strong the market expansion.
 

Increasing usage of minimally invasive procedures and launch of innovative products to augment demand for catheters

To tailor this report to your specific requirements: Customize this Report
 

The catheters segment in the peripheral interventions market is anticipated to showcase 8.6% growth rate through 2028 led by the benefits associated with it such as technological advancements, easy diagnosis, and better outcomes through use of catheters. A catheter is an important part of a peripheral interventional procedure since it is used to diagnose and treat blockages in blood arteries. Catheter developments have further enabled healthcare practitioners to visualise and operate lesions in vessels, as well as give suitable disease treatment, resulting in future segment growth of peripheral interventions.
 

Growing geriatric population and rising incidence of vascular disorders will increase the demand for peripheral intervention procedures

The peripheral artery disease segment dominated more than 53% of revenue share in 2021. Rising prevalence of peripheral artery diseases will accelerate the adoption of various peripheral vascular devices. Application of peripheral interventions in treatment of peripheral arterial diseases is used to reduce the blockages in the blood vessels formed owing to rising risk factors such as smoking and consumption of high cholesterol food. Increasing incidence of coronary and peripheral atrial diseases is further fuelling the demand for atherectomy devices.
 

Skilled workforce and sophisticated infrastructure to spur the demand for peripheral vascular devices in hospitals

Hospitals segment accounted for 84% of the peripheral interventions market share in 2021. The sales of peripheral interventions products in hospitals are slated to increase in future owing to rise in number of people opting for treatment in hospitals due to better expertise and accessibility. Hospitals offer sophisticated treatment, easy availability of advanced devices and presence of skilled workforce at one place, are collectively driving the patient preference for hospitals, thereby promoting the industry progression.
 

Growing healthcare expenditure and presence of major companies will positively impact the North America market value

North America peripheral interventions market held over 40% of revenue share in 2021. Presence of major players in the region and skilled workforce in the healthcare settings will positively impact the market demand in the region. Major leaders such as Johnson & Johnson, Medtronic, Becton Dickinson and Boston Scientific Corporation have a strong presence in North America, particularly in the U.S. market, and healthcare professionals in the region quickly adopt breakthrough products, resulting in lucrative opportunities for the companies operating in the industry.
 

A large population suffering from various CVDs places a financial burden on the healthcare system. Every year, Americans spend more than USD 200 billion on CVDs. With growing costs, the need for effective treatment is also increasing, this led to potential innovation in market. Additionally, increasing awareness regarding early diagnosis and treatment of PAD in Canada will further impel the demand for market in the region.
 

New product development and geographical expansion are key strategies adopted by major market leaders

Major participants involved in the market include Abbott Laboratories, AngioDynamics Inc., Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Medical, W. L. Gore & Associates Inc, Teleflex Incorporated, Medtronic, Becton Dickinson and Company (C.R. Bard), Cardinal Health Inc, B. B. Braun Melsungen AG, Terumo Corporation, Meril Life Sciences Pvt. Ltd, and DePuy Synthes (Johnson & Johnson). These market leaders have incorporated certain strategic initiatives such as new product development and launch, collaborations, acquisitions and others that have enhanced their industry hold and helped them evolve as major industry players.
 

Peripheral Interventions Market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2028 for the following segments:

Click here to buy sections of this report

Market, By Product

• Catheters
• Sheath
• Stents
  • Bare-metal Stents
  • Drug-eluting Stents
  • Others
• Guide Wires
• Atherectomy Devices
• Embolic Devices
• Thrombectomy Devices
• IVC Filters
• Others

Market, By Application

• Peripheral Artery Disease
• Venous Thromboembolism
• Others

Market, By End-use

• Hospitals
• Catheterization Laboratories
• Ambulatory Surgical Centres
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE